口服避孕药对脂代谢影响的研究进展

发布时间：2018-03-27 13:10

本文选题：口服避孕药　切入点：炔雌醇　出处：《山东医药》2015年17期

【摘要】：目的口服避孕药是由雌激素配伍不同类型的孕激素组成的,已成为当今女性主要的避孕方式之一。本文认为,口服避孕药会引起脂代谢紊乱(是冠状动脉疾病的危险因素),增加患心血管疾病的危险,且口服避孕药对脂代谢的影响与雌孕激素的剂量有关。小剂量的雌激素可升高HDL、TG,降低LDL水平,而大剂量的雌激素可导致HDL降低。提倡女性选择含雄激素活性较小的孕激素为主的口服避孕药,服用药物前先了解此药物的禁忌,并在专科医生的指导下正确用药,定期监测血脂,及时发现异常并治疗。
[Abstract]:Objective the oral contraceptive is composed of estrogen and different types of progesterone, and has become one of the main contraceptive methods in women. Oral contraceptives can cause lipid disorders (a risk factor for coronary artery disease) and increase the risk of cardiovascular disease. The effect of oral contraceptive on lipid metabolism was related to the dose of estrogen and progesterone. Large doses of estrogen can lead to lower HDL. Women are encouraged to choose oral contraceptives with low androgen activity, know the contraindications before taking the drug, and use it correctly under the guidance of a specialist. Monitor blood lipids regularly, detect abnormalities and treat them in time.
【作者单位】：广西医科大学;
【分类号】：R979.21

【参考文献】